# EDGAR Filing Document

**Accession Number:** 0001269026
**File Stem:** 0001493152-26-007271
**Filing Date:** 2026-2
**Character Count:** 54427
**Document Hash:** ab91e5056118bf3ac404ee1a391ad21c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-26-007271.hdr.sgml**: 20260218

**ACCESSION NUMBER**: 0001493152-26-007271

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 13

**CONFORMED PERIOD OF REPORT**: 20260218

**ITEM INFORMATION**: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260218

**DATE AS OF CHANGE**: 20260218

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Sintx Technologies, Inc.
- **CENTRAL INDEX KEY:** 0001269026
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-33624
- **FILM NUMBER:** 26645581

**BUSINESS ADDRESS:**
- **STREET 1:** 1885 WEST 2100 STREET
- **CITY:** SALT LAKE CITY
- **STATE:** UT
- **ZIP:** 84119
- **BUSINESS PHONE:** 801-839-3516

**MAIL ADDRESS:**
- **STREET 1:** 1885 WEST 2100 STREET
- **CITY:** SALT LAKE CITY
- **STATE:** UT
- **ZIP:** 84119

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** AMEDICA Corp
- **DATE OF NAME CHANGE:** 20121231

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** AMEDICA CORP
- **DATE OF NAME CHANGE:** 20031104

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

Date of Report (Date of earliest event reported): **February 18, 2026**

**SINTX Technologies, Inc.**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-33624** | **84-1375299** |
| (State or other jurisdiction<br> of incorporation) | (Commission<br> File Number) | (IRS Employer<br> Identification No.) |

---

**1885 West 2100 South**

**Salt Lake City, UT 84119**

(Address of principal executive offices, including Zip Code)

Registrant's telephone number, including area code: **(801) 839-3500**

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class:** | **Trading Symbol(s):** | **Name of each exchange on which registered:** |
| Common Stock, par value $0.01 per share | SINT | The NASDAQ Capital Market |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.**

**(b) Change in Officer Position**

Effective March 16, 2026, Eric Olson will cease serving as President of SINTX Technologies, Inc. (the "Company") and will continue to serve as Chairman of the Board and Chief Executive Officer of the Company.

**(c) Appointment of President**

On February 17, 2026, the Company announced the appointment of Ryan Elmore as President of the Company, effective March 16, 2026. Mr. Elmore will report to the Company's Chief Executive Officer.

Mr. Elmore has over 20 years of leadership experience in the medical device and life sciences industries, including senior executive roles with responsibility for research and development, commercial operations, and international business expansion. Prior to joining the Company, Mr. Elmore served in various leadership positions at Invibio, a division of Victrex plc. He most recently served as Core Business Director since September 2021, where he was responsible for commercial leadership within advanced biomaterials and medical device markets. From October 2010 to November 2021, he served as Global Head of Sales, with responsibility for global commercial strategy and sales execution.

There are no arrangements or understandings between Mr. Elmore and any other person pursuant to which he was selected as President. There are no family relationships between Mr. Elmore and any director or executive officer of the Company, and there are no related party transactions involving Mr. Elmore that would require disclosure under Item 404(a) of Regulation S-K.

**(c)(3) Executive Employment Agreement**

In connection with his appointment, the Company entered into an Executive Employment Agreement with Mr. Elmore, effective February 6, 2026, with an employment commencement date of March 16, 2026.

Pursuant to the agreement:

● **Base Salary:** $375,000 per year.

● **Annual Bonus:** Eligible for an annual cash bonus with a target opportunity of 35% of base salary. Mr. Elmore's annual bonus for his first year of employment is guaranteed.

● **Sign-On Bonus:** $100,000 payable upon commencement of employment, subject to repayment if Mr. Elmore voluntarily terminates employment within twelve months of his start date.

● **Equity Awards:** Upon commencement of employment, Mr. Elmore will receive a restricted stock unit award with a grant date value of $300,000, with 20% vesting on the grant date and the remainder vesting in equal installments over the following 24 months, subject to continued employment. He will also be eligible to receive additional equity awards, including awards tied to the achievement of specified international business milestones.

● **Benefits:** Eligible to participate in the Company's employee benefit plans available to senior executives.

The agreement provides that if Mr. Elmore's employment is terminated by the Company without cause or by Mr. Elmore for good reason, he will be entitled to receive accrued compensation and severance benefits, including a cash payment equal to two times the sum of his base salary and target bonus and continued health benefit coverage (or cash payments in lieu thereof) for up to 24 months, subject to execution of a release of claims. The agreement provides for enhanced severance protections in connection with certain change in control events.

Mr. Elmore's employment is subject to customary pre-employment conditions, including successful completion of background and drug screening.

The foregoing description of the Executive Employment Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the agreement, which is filed as Exhibit 10.1 hereto and incorporated herein by reference.

**Item 9.01 Financial Statements and Exhibits.**

(d) Exhibits.

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| 10.1\* | [Executive Employment Agreement, dated February 6, 2026, by and between SINTX Technologies, Inc. and Ryan Elmore](ex10-1.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

\*Certain immaterial provisions of the Executive Employment Agreement have been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K because the omitted information is not material and would likely cause competitive harm to the Company if publicly disclosed.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
|  |  | SINTX Technologies, Inc. | SINTX Technologies, Inc. |
| Date: | February 18, 2026 | By: | */s/ Eric K. Olson* |
|  |  |  | Eric K. Olson |
|  |  |  | Chief Executive Officer |

---

## Exhibit 10.1

**Exhibit 10.1**

Certain identified information has been omitted from this exhibit because it is both (i) not material and (ii) would likely cause competitive harm to the registrant if publicly disclosed. Information that has been omitted has been noted in this exhibit with brackets ([\*\*\*]).

**Executive Employment Agreement**

This EXECUTIVE EMPLOYMENT AGREEMENT ("**Agreement**") is made and entered into as of February 6, 2026 (the "**Effective Date**"), by and between SINTX Technologies, Inc. (together with its successors and assigns, the "**Company**"), and Ryan Elmore ("**Executive**").

**RECITALS**

WHEREAS, the Company desires to employ Executive, and Executive desires to be employed by the Company, as the Company's President reporting to the Company's Chief Executive Officer.

WHEREAS, Company and Executive now desire to enter into this Agreement.

Certain identified information has been omitted from this exhibit because it is both (i) not material and (ii) would likely cause competitive harm to the registrant if publicly disclosed. Information that has been omitted has been noted in this exhibit with brackets ([\*\*\*]).

NOW, THEREFORE, in consideration of the foregoing recitals, the mutual covenants and conditions herein, and other good and valuable consideration, the receipt and adequacy of which is hereby acknowledged, the parties hereby agree as follows:

**AGREEMENT**

**1.** **Employment, Term and Start Date.** 

&nbsp;&nbsp;&nbsp;&nbsp;**(a)** **Term and Start Date.** The Company hereby agrees to employ Executive, and Executive hereby accepts
 employment by the Company, on the terms and conditions hereinafter set forth. Executive's
 term of employment by the Company under this Agreement (the "**Term**") shall
 commence on March 16, 2026 (the "**Start Date**") and end on the third anniversary
 thereof, subject to automatic renewal of the Term for additional one-year periods unless
 either the Company or Executive gives the other party written notice of intent not to renew
 the Term not less than ninety days before the date on which the Term otherwise would automatically
 renew. Notwithstanding the foregoing, the Term may be terminated earlier in accordance with
 Section 5.

**(b)** **No Services Prior to Start Date.** Notwithstanding the Effective Date of this Agreement, Executive
 shall not be deemed an employee of the Company and shall not be required or permitted to
 perform services for the Company prior to the Start Date. Except as expressly provided herein,
 no compensation, benefits, equity vesting, service credit, or other employment-related rights
 shall accrue or be payable prior to the Start Date.

**(c)** **Background Check and Drug Test.** Executive's employment with the Company and the commencement
 of the Term are expressly **conditioned upon Executive** ' **s successful completion, to the Company** ' **s reasonable satisfaction, of any required background check and drug screening in accordance with the Company** ' **s policies applicable to senior executives,** and Executive's authorization of the same. If Executive fails
 to successfully complete any such background check or drug screening, or fails to timely
 cooperate with the Company's requests in connection therewith, **the Company may rescind this Agreement and/or terminate this Agreement prior to the Start Date,** and Executive
 shall not be entitled to any compensation, severance, or benefits under this Agreement other
 than rights that expressly survive termination.

**2.** **Position, Duties and Responsibilities, Location, and Commuting.** 

&nbsp;&nbsp;&nbsp;&nbsp;**(a)** **Position and Duties.** During the Term, the Company shall employ Executive to serve as its President.
 Executive shall report directly to the Company's Chief Executive Officer. Executive's
 duties shall include those duties set forth on Appendix A, attached hereto, and such other
 duties as may be assigned to Executive from time to time.

**(b)** **Exclusive Services and Efforts.** Executive agrees to devote his efforts, energies, and skill to
 the discharge of the duties and responsibilities attributable to his position and, except
 as set forth herein, agrees to devote substantially all of his professional time and attention
 to the business and affairs of the Company. Notwithstanding the foregoing, Executive shall
 be entitled to engage in (a) service on the board of directors of for-profit and not-for-profit
 companies, organizations, businesses or trade organizations at any time during the Term (provided
 that Executive shall not serve on the board of any entity that materially competes with the
 Company), (b) other charitable activities and community affairs, and (c) management
 of his personal and family investments and affairs, in each case to the extent such activities
 do not, either individually or in the aggregate, materially interfere with the performance
 of his duties and responsibilities to the Company.

**(c)** **Compliance with Company Policies.** To the extent not inconsistent with the terms and conditions of
 this Agreement and with due regard for his position, Executive shall be subject to the Bylaws,
 policies, practices, procedures, and rules of the Company, including those policies and procedures
 set forth in the Company's Code of Conduct and Ethics and Employee Handbook, but in
 no event shall anything in such documents be construed to expand the definition of Cause
 hereunder.

**(d)** **Location of Employment.** The Executive's principal office and principal place of employment
 ("Home Base"), shall be in the Company's corporate office in Philadelphia,
 Pennsylvania; provided that Executive will be required under business circumstances to travel
 outside of such location in connection with performing his or her duties under this Agreement.

**(e)** **Employee Confidentiality, Intellectual Property and Non-Solicitation Agreement.** As
 a condition of employment, the Executive shall be required to sign the Company's standard
 Employee Confidentiality, Intellectual Property and Non-Solicitation Agreement. This agreement
 shall include, among other provisions, an obligation not to solicit the Company's customers
 or employees for a period of eighteen (18) months following the Executive's departure
 from the Company. The agreement will also contain a non-compete provision specifically tailored
 to the medical device and biomaterials sectors, subject to applicable Utah and international
 employment law limitations. Exceptions to these restrictions may be negotiated in advance,
 depending on operational needs and as approved by the Company.

**3.** **Compensation.** 

&nbsp;&nbsp;&nbsp;&nbsp;**(a)** **Base Salary.** During the first year of the Term, the Company shall pay to Executive an annual
 salary of $375,000.00 ()"**Base Salary** "). Base Salary shall commence accruing
 as of the Start Date. Thereafter, the Compensation Committee of the Board (the "**Committee** ")
 shall consider increases in Base Salary for subsequent years in connection with performance
 and a review of compensation provided at peer companies, which companies shall be subject
 to review on a continuing basis (the "**Peer Group** "), taking into account
 Company and individual performance objectives. Executive's Base Salary shall not be
 decreased (including after any increases pursuant to this Section 3(a)) without Executive's
 written consent.

**(b)** **Annual Cash Bonus.** During the Term, Executive shall have an annual target cash bonus opportunity
 of 35% of one year's Base Salary. The Committee shall award Executive's annual
 cash bonus based on an evaluation of performance and Peer Group compensation practices, taking
 into account Company and individual performance objectives. In its sole discretion, the Committee
 may award an annual cash bonus in excess of the annual cash bonus opportunity. Notwithstanding
 the foregoing, the Committee may grant a special bonus at any time. Annual cash bonuses shall
 be deemed "earned" if Executive is employed on the last day of the year to which
 the bonus relates and shall be paid no later than March 15th of the year immediately following
 the year to which the annual bonus relates. Executive's bonus for his first year of
 employment is guaranteed and shall be paid on or prior to March 15, 2027.

**(c)** **Annual Long-Term Incentive Award.** During the Term, Executive will be eligible for an annual
 target long-term incentive award opportunity as determined by the Committee based on an evaluation
 of performance and Peer Group compensation practices, taking into account Company and individual
 performance objectives. Notwithstanding the foregoing, the Committee may grant a special
 long-term incentive award at any time. Awards granted under the Equity Incentive Plan shall
 be subject to the terms and conditions of such plan and the award agreement.

**(d)** **RSU Award.** Effective as of the Start Date, Executive shall
 be granted an award of restricted stock units ("RSUs") with a total grant date
 value of $300,000.00. The exact number of RSUs to be granted shall be calculated by dividing
 $300,000.00 by the closing price of the Company's common stock as reported on the Nasdaq
 Capital Market on the Start Date (the "Grant Date"). Any resulting fractional
 RSU shall be rounded up to the nearest whole unit. The RSUs shall vest as follows: 20% of
 the total RSU award shall vest immediately on the Grant Date, and the remaining 80% shall
 vest in equal 20% installments every six months thereafter, such that the RSUs will be fully
 vested after 24 months from the Grant Date, subject to Executive's continued employment
 with the Company on each applicable vesting date.

**(e)** **Additional RSU Grants for International Achievements.** In addition to the initial RSU award described
 above, Executive shall be eligible to receive additional grants of restricted stock units
 ("RSUs") upon the occurrence of the following international business milestones,
 including: (a) Achievement of defined international sales milestones, as determined and approved
 by the Board of Directors; (b) Signing of major international distribution agreements, as
 identified and approved by the Board of Directors; (c) Establishment of profitable international
 operations, as evidenced by audited financial statements and approved by the Board of Directors.
 Each additional RSU grant shall be subject to terms and conditions, including grant value
 and vesting schedule, as determined by the Board of Directors at the time of the award.

&nbsp;&nbsp;&nbsp;&nbsp;**(f)** **Sign-on Cash Bonus.** Upon commencement of employment on the Start Date, the Executive shall receive
 a sign-on cash bonus in the amount of $100,000, payable on the Executive's Start Date,
 subject to applicable federal and state tax withholding. If the Executive voluntarily terminates
 employment with the Company within twelve (12) months following the Start Date, the
 Executive agrees to repay the full amount of the sign-on bonus to the Company within thirty
 (30) days of such termination.

**4.** **Employee Benefits and Perquisites.** 

&nbsp;&nbsp;&nbsp;&nbsp;**(a)** **Benefits.** Executive shall be entitled to participate in such health, group insurance, welfare, pension,
 and other employee benefit plans, programs, and arrangements as are made generally available
 from time to time to senior executives of the Company (which shall include customary health,
 life insurance, and disability plans), such participation in each case to be on terms and
 conditions no less favorable to Executive than to other senior executives of the Company
 generally. Executive's participation in Company benefit plans shall commence as of
 the Start Date, subject to plan terms.

**(b)** **Fringe Benefits, Perquisites, and Paid Time Off.** During the Term, Executive shall be entitled
 to participate in all fringe benefits and perquisites made available to other senior executives
 of the Company, such participation to be at levels, and on terms and conditions, that are
 commensurate with his position and responsibilities at the Company and that are no less favorable
 than those applicable to other senior executives of the Company. Executive shall be eligible
 for paid time off ()"**PTO**") in accordance with the Company's vacation
 and PTO policy.

**(c)** **Reimbursement of Expenses.** The Company shall reimburse Executive for all reasonable business and travel
 expenses incurred in the performance of his job duties and the promotion of the Company's
 business, promptly upon presentation of appropriate supporting documentation and otherwise
 in accordance with the expense reimbursement policy of the Company.

**5.** **Termination; Change in Control.** 

&nbsp;&nbsp;&nbsp;&nbsp;**(a)** **General.** The Company may terminate Executive's employment for Cause. Executive may terminate
 his employment at any time for any reason other than Good Reason. The Company may terminate
 Executive's employment without Cause, or Executive may terminate Executive's
 employment with Good Reason, in each case, upon providing the other party at least thirty
 days' written notice thereof. Upon termination of Executive's employment, Executive
 shall be entitled to the compensation and benefits described in this Section 5 to the extent
 applicable and shall have no further rights to any compensation or benefits from the Company.
 For purposes of this Agreement, the following terms have the following meanings:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) "**Accrued Benefits**" shall mean: (i) accrued but unpaid Base Salary through the Termination
 Date, payable within thirty days following the Termination Date; (ii) any annual cash bonus
 earned but unpaid with respect to the year preceding the year in which the Termination Date
 occurs, payable in accordance with Section 3(b) above; (iii) any long-term incentive award
 earned but unpaid with respect to performance periods that ended in the year preceding the
 year in which Termination Date occurs, payable in accordance with Section 3(c) above; (iv)
 reimbursement for any unreimbursed business expenses incurred through the Termination Date
 and any expenses incurred through the Termination Date under Section 4(c) above, payable
 within thirty days following the Termination Date; (v) accrued but unused PTO days in accordance
 with Company policy; and (vi) all other payments, benefits, or fringe benefits to which Executive
 shall be entitled as of the Termination Date under the terms of this Agreement or any other
 applicable compensation arrangement or benefit, equity, or fringe benefit plan or program
 or grant.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) "**Cause** "
 shall mean: (i) the Executive's commission of a felony (other than through vicarious
 liability or through a motor vehicle offense); (ii) intentional misconduct that causes material
 harm to the Company, provided that such misconduct is not rectifiable or remains uncorrected
 after written notice and a 30-day cure period; (iii) the commission by the Executive of
 an act of fraud, embezzlement or misappropriation of funds; (iv) a material breach by the
 Executive of any material provision of this Agreement or any other agreement to which the
 Executive and the Company are party, which breach is not cured within thirty (30) days after
 delivery to the Executive by the Company of written notice of such breach; or (v) the Executive's
 refusal to carry out a lawful written directive from the CEO and/or Board which is within
 Executive's normal Company duties. Any determination of Cause will need to be made
 by the full Board voting on such determination.

(iii) "**Good Reason**" shall mean any of the following that has not been approved in writing in
 advance by Executive: (i) a diminution of Executive's titles, duties, responsibilities,
 or authorities as set forth in this Agreement; (ii) a reduction in Executive's Base
 Salary, annual cash bonus opportunity, or annual long-term incentive award opportunity, or
 failure to pay earned compensation; (iii) relocation of the Company's offices to a
 location more than thirty miles from the Executive's Home Base; (iv) a material breach
 by the Company of this Agreement or any equity award agreement; or (v) a material change
 in the Executive's compensation or authority, functions, duties or responsibilities,
 which would cause his position with the Company to become of less responsibility, importance
 or scope than his position on the date of this Agreement or as of any subsequent date prior
 to a Change in Control, provided, however, that such material change is not in connection
 with the termination of the Executive's employment by the Company for any reason.
 A termination of employment by Executive during the one-year period following the occurrence
 of an event or circumstance constituting Good Reason shall be deemed a termination for Good
 Reason under this Agreement. In addition, any termination of employment by Executive during
 the one-year period following a Change in Control shall be deemed to be a termination for
 Good Reason under this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) "**Change in Control**" means (i) any "person" (as such term is used in Sections
 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended (the "Act"))
 becomes the "beneficial owner" (as defined in Rule 13d-3 under the Act), directly
 or indirectly, of securities of the Company representing 50% or more of the total voting
 power represented by the Company's then outstanding voting securities (excluding for
 this purpose the Company or its Affiliates or any employee benefit plan of the Company) pursuant
 to a transaction or a series of related transactions of which the Board does not approve;
 (ii) a merger or consolidation of the Company, whether or not approved by the Board, other
 than a merger or consolidation which would result in the voting securities of the Company
 outstanding immediately prior thereto continuing to represent (either by remaining outstanding
 or by being converted into voting securities of the surviving entity or the parent of such
 corporation) at least 50% of the total voting power represented by the voting securities
 of the Company or such surviving entity or parent of such corporation outstanding immediately
 after such merger or consolidation; (iii) the stockholders of the Company approve an agreement
 for the sale or disposition by the Company of all or substantially all of the Company's
 assets; or a change in the composition of the Board of Directors whereby individuals who
 were members of the Board immediately prior to the agreement cease to constitute a majority
 of the Board. For purposes of this Agreement, "Change in Control" shall be interpreted
 in a manner, and limited to the extent necessary, so that it will not cause adverse tax consequences
 for either party with respect to Section 409A of the Internal Revenue Code of 1986, as amended
 (the "Code"), and the treasury regulations issued thereunder or any guidance
 issued by the IRS concerning the interpretation or applicability of Section 409A of the Code.

(v) "**Change-in-Control Severance Payments**" shall mean (i) a pro-rated annual cash bonus for the year in
 which the Termination Date occurs (calculated based on the annual target cash bonus opportunity
 for the year of termination), payable when bonuses are paid to other executives of the Company
 in the year following the year of the Termination Date; (ii) a lump sum cash payment, payable
 on the Termination Date, equal to two times the sum of the following: (x) one year's
 Base Salary at the annualized rate then in effect (or the rate that should be in effect but
 for any Base Salary diminution), and, (y) the greater of the annual target cash bonus opportunity
 for the year of termination or the highest actual annual cash bonus paid during the three
 preceding completed years (provided, however, that if Executive has not been employed for
 at least three years in which an annual cash bonus was paid, such calculation will assume
 that an annual cash bonus equal to the target annual cash bonus opportunity was paid in the
 missing years); (iii) Medical Payment Amounts, payable each month, commencing on the first
 day of the month following the Termination Date and continuing until the earlier of twenty
 four months following the Termination Date or the date on which Executive becomes employed
 by a third party and becomes eligible to participate in such third party's group health
 plan; and (iv) to the extent permissible under applicable law and under any insurance policy
 insuring the Company's health plan (if any), access to continued coverage under the
 Company's health plan with the full cost payable by Executive for a period of up to
 twenty four months commencing on the first day of the month following the Termination Date.
 Executive shall be entitled to the Change-in-Control Severance Payment should Executive's
 employment be terminated, other than for Cause, within one year of the occurrence of a Change-in-Control.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi) "**Disability** "
 shall mean that Executive has been unable, with or without reasonable accommodation and due
 to physical or mental incapacity, to substantially perform his duties and responsibilities
 hereunder for 120 consecutive days.

(vii) "**Medical Payment Amounts**" shall mean an amount, payable on a monthly basis commencing on
 the first day of the month following the Termination Date, equal to (i) the monthly amount
 of the Consolidated Omnibus Budget Reconciliation Act continuation coverage premium for such
 month under the Company's group medical plans for executives of the Company less the
 monthly amount of Executive's portion of the premium for such month as if Executive
 was still an active employee, plus (ii) a tax gross-up payment so Executive shall have no
 after-tax consequences with respect to the monthly amount described in clause (i) or the
 related tax gross-up.

(viii) "**Severance Payments**" shall mean (i) a lump sum cash payment, payable on the Termination Date,
 equal to two times the sum of the following: (x) one year's Base Salary at the annualized
 rate then in effect (or the rate that should be in effect but for any Base Salary diminution),
 (y) the greater of (I) the annual target cash bonus opportunity for the year of termination
 or (II) the average annual cash bonus for the three preceding completed years (provided,
 however, that if Executive has not been employed for at least three years in which an annual
 cash bonus was paid, such calculation will assume that an annual cash bonus equal to the
 target annual cash bonus opportunity was paid in the missing years); (ii) Medical Payment
 Amounts payable each month and continuing until the earlier of twenty four months following
 the Termination Date or the date on which Executive becomes employed by a third party and
 becomes eligible to participate in such third party's group health plan; and (iii)
 to the extent permissible under applicable law and under any insurance policy insuring the
 Company's health plan (if any), access to continued coverage under the Company's
 health plan with the full cost payable by Executive for a period of up to twenty-four months
 commencing on the first day of the month following the Termination Date.

(ix) "**Termination Date**" shall mean the date on which Executive's employment hereunder terminates
 in accordance with this Agreement (which, in the case of a notice of non-renewal of the Term
 in accordance with Section 1 hereof, shall mean the date on which the Term expires).

&nbsp;&nbsp;&nbsp;&nbsp;**(b)** **Termination Without Cause or Termination by Executive for Good Reason.** In the event that Executive's
 employment hereunder is terminated by the Company without Cause or by Executive for Good
 Reason, Executive shall be entitled to receive the Accrued Benefits and the Severance Payments,
 except as otherwise provided pursuant to Section 5(d).

**(c)** **Termination Without Cause or Termination by Executive for Good Reason Due to a Change in Control.** In the event that Executive's employment hereunder is terminated by the Company without
 Cause or by Executive for Good Reason within one year following or six months prior to a
 Change in Control, Executive shall receive the benefits described in Section 5(b), except
 that Executive shall receive the Change-in-Control Severance Payments in lieu of the Severance
 Payments.

&nbsp;&nbsp;&nbsp;&nbsp;**(d)** **Termination Due to Death or Disability.** In the event that Executive's employment hereunder
 is terminated due to Executive's death or Disability, Executive shall receive the Accrued
 Benefits.

**(e)** **Pre-Start Date Termination.** If this Agreement is terminated by either party prior to the Start
 Date, Executive shall not be entitled to any severance payments, compensation, or benefits
 under this Agreement, other than rights that expressly survive termination, including confidentiality,
 restrictive covenants, and indemnification provisions.

**(f)** **Return of Company Property.** Upon termination of Executive's employment for any reason
 or under any circumstances, Executive shall promptly return any and all of the property of
 the Company and any Affiliates (including, without limitation, all computers, keys, credit
 cards, identification tags, documents, data, confidential information, work product, and
 other proprietary materials), and other materials. Executive may retain Executive's
 rolodex and similar address books provided that such items only include contact information.

**(g)** **Post-Termination Reasonable Cooperation.** Executive agrees and covenants that, following the Term, Executive
 shall, to the extent reasonably requested by the Company, cooperate in good faith with the
 Company to assist the Company in the pursuit or defense of (except if Executive is adverse
 with respect to) any claim, administrative charge, or cause of action by or against the Company
 as to which Executive, by virtue of his employment with the Company or any other position
 that Executive holds that is affiliated with or was held at the request of the Company or
 its Affiliates, has relevant knowledge or information, including by acting as the Company's
 representative in any such proceeding and, without the necessity of a subpoena, providing
 truthful testimony in any jurisdiction or forum. The Company shall reimburse Executive for
 his reasonable out-of-pocket expenses incurred in compliance with this Section 5(g), including
 any reasonable travel expenses and reasonable attorneys' fees incurred by Executive
 and, in the event that Executive is required to spend substantial time on such matters, the
 Company shall compensate Executive at an hourly rate to be agreed to. The Company shall use
 reasonable business efforts to provide Executive with reasonable advance written notice of
 its need for Executive's reasonable cooperation and shall attempt to coordinate with
 Executive the time and place at which Executive's reasonable cooperation shall be provided
 with the goal of minimizing the impact of such reasonable cooperation on any other material
 pre-scheduled business commitment that Executive may have. Executive's cooperation
 described in this Section 5(g) shall be subject to the maintenance of the indemnification
 and D&O insurance policy provided under Sections 6(a) and (b) hereof.

**(h)** **Mutual Release.** Payment of any Change-in-Control Severance Payments and Severance Payments shall
 be conditioned upon the execution, non-revocation, and delivery of a general mutual release
 of claims by Executive, in a form reasonably satisfactory to the Company. In the event that
 Executive fails to timely execute and deliver such a release, the Company shall have no obligation
 to pay Change-in-Control Severance Payments or Severance Payments under this Agreement.

**6.** **Indemnification; D&O Insurance.** 

&nbsp;&nbsp;&nbsp;&nbsp;**(a)** **Indemnification.** If Executive is made a party, is threatened to be made a party, or reasonably anticipates
 being made a party, to any Proceeding (as hereinafter defined) by reason of the fact that
 Executive is or was a director, officer, shareholder, employee, agent, trustee, consultant,
 or representative of the Company or any of its Affiliates or is or was serving at the request
 of the Company or any of its Affiliates, or in connection with his service hereunder as a
 director, officer, shareholder, employee, agent, trustee, consultant, or representative of
 another Person, or if any Claim (as hereinafter defined) is made, is threatened to be made,
 or is reasonably anticipated to be made, that arises out of or relates to Executive's
 service in any of the foregoing capacities, then Executive shall promptly be indemnified
 and held harmless to the fullest extent permitted or authorized by any Company arrangement,
 or if greater, by applicable law, against any and all costs, expenses, liabilities, and losses
 (including, without limitation, advancement and payment of attorney's and other professional
 fees and charges, judgments, interest, expenses of investigation, penalties, fines, ERISA
 excise taxes or penalties, and amounts paid or to be paid in settlement, with such legal
 fees advanced to the maximum extent permitted by law) incurred or suffered by Executive in
 connection therewith or in connection with seeking to enforce his rights under this Section
 6(a), and such indemnification shall continue even if Executive has ceased to be a director,
 officer, shareholder, employee, agent, trustee, consultant, or representative of the Company
 or other Person and shall inure to the benefit of his heirs, executors, and administrators.
 This benefit shall be in addition to the provisions of any Indemnity Agreement entered into
 between Executive and Company.

**(b)** **D&O Insurance.** A directors' and officers' liability insurance policy (or policies)
 shall be kept in place, during the Term and thereafter until the sixth anniversary of the
 Termination Date, providing coverage to Executive that is no less favorable to Executive
 in any respect than the coverage then being provided to any other current or former director
 or officer of the Company.

**(c)** **Definitions.** For purposes of this Agreement, the following terms shall have the following meanings: "**Affiliate** "
 of a Person shall mean any Person that directly or indirectly controls, is controlled by,
 or is under common control with, such Person; "**Claim**" shall mean any claim,
 demand, request, investigation, dispute, controversy, threat, discovery request, or request
 for testimony or information; "**Person**" shall mean any individual, corporation,
 partnership, limited liability company, joint venture, trust, estate, board, committee, agency,
 body, employee benefit plan, or other person or entity; and "**Proceeding** "
 shall mean any threatened or actual action, suit, or proceeding, whether civil, criminal,
 administrative, investigative, appellate, formal, informal, or other.

**7.** **Other Tax Matters.** 

&nbsp;&nbsp;&nbsp;&nbsp;**(a)** **Withholding.** The Company shall withhold all applicable federal, state, and local taxes, social security,
 and workers' compensation contributions and other amounts as may be required by law
 with respect to compensation payable to Executive pursuant to this Agreement.

**(b)** **Section 409A.** Notwithstanding anything herein to the contrary, this Agreement is intended to
 be interpreted and applied so that the payment of the benefits set forth herein shall either
 be exempt from, or in the alternative, comply with, the requirements of Section 409A of the
 Internal Revenue Code of 1986, as amended (the "**Code** "), and the published
 guidance thereunder ()"**Section 409A** "). A termination of employment shall
 not be deemed to have occurred for purposes of any provision of this Agreement providing
 for the payment of any amounts or benefits upon or following a termination of employment
 that are considered "nonqualified deferred compensation" under Section 409A unless
 such termination is also a "separation from service" within the meaning of Section
 409A and, for purposes of any such provision of this Agreement, references to a "termination,"
 "Termination Date" or like terms shall mean "separation from service."
 Notwithstanding any provision of this Agreement to the contrary, if Executive is a "specified
 employee" within the meaning of Section 409A on the date of Executive's "separation
 from service," any payments or arrangements due upon a termination of Executive's
 employment under any arrangement that constitutes a "nonqualified deferral of compensation"
 within the meaning of Section 409A and which do not otherwise qualify under the exemptions
 under Treas. Regs. Section 1.409A-1 (including without limitation, the short-term deferral
 exemption or the permitted payments under Treas. Regs. Section 1.409A-1(b)(9)(iii)(A)), shall
 be delayed and paid or provided on the earlier of (a) the date which is six months after
 Executive's "separation from service" for any reason other than death,
 or (b) the date of Executive's death. All tax gross-up payments provided under this
 Agreement or any other agreement with Executive shall be made or provided by the end of Executive's
 taxable year next following Executive's taxable year in which Executive remits the
 related taxes, in accordance with the requirements of Section 409A.

**(c)** **Separation from Service.** After any Termination Date, Executive shall have no duties or responsibilities
 that are inconsistent with having a "separation from service" within the meaning
 of Section 409A as of the Termination Date and, notwithstanding anything in the Agreement
 to the contrary, distributions upon termination of employment of nonqualified deferred compensation
 may only be made upon a "separation from service" as determined under Section
 409A and such date shall be the Termination Date for purposes of this Agreement. Each payment
 under this Agreement or otherwise shall be treated as a separate payment for purposes of
 Section 409A. In no event may Executive, directly or indirectly, designate the calendar year
 of any payment to be made under this Agreement which constitutes a "nonqualified deferral
 of compensation" within the meaning of Section 409A and to the extent an amount is
 payable within a time period, the time during which such amount is paid shall be in the discretion
 of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;**(d)** **Reimbursements.** All reimbursements and in-kind benefits provided under this Agreement shall be made or provided
 in accordance with the requirements of Section 409A. To the extent that any reimbursements
 are taxable to Executive, such reimbursements shall be paid to Executive on or before the
 last day of Executive's taxable year following the taxable year in which the related
 expense was incurred. Reimbursements shall not be subject to liquidation or exchange for
 another benefit and the amount of such reimbursements that Executive receives in one taxable
 year shall not affect the amount of such reimbursements that Executive receives in any other
 taxable year.

**(e)** **Parachute Payments.** If any payment, benefit, or distribution of any type to or for the benefit
 of Executive, whether paid or payable, provided or to be provided, or distributed or distributable
 pursuant to the terms of this Agreement or otherwise (collectively, the "Parachute
 Payments") would (as determined by the Company) subject Executive to the excise tax
 imposed under Section 4999 of the Code (the "Excise Tax"), the Parachute Payments
 shall be reduced so that the maximum amount of the Parachute Payments (after reduction) shall
 be one dollar less than the amount which would cause the Parachute Payments to be subject
 to the Excise Tax. The Company shall reduce or eliminate the Parachute Payments by first
 reducing or eliminating any cash Parachute Payments that do not constitute deferred compensation
 within the meaning of Section 409A, then by reducing or eliminating any other Parachute Payments
 that do not constitute deferred compensation within the meaning of Section 409A, then by
 reducing or eliminating all other Parachute Payments that do constitute deferred compensation
 within the meaning of Section 409A, beginning with those payments last to be paid, subject
 to and in accordance with all applicable requirements of Section 409A.

**8.** **Notices.** Except as otherwise specifically provided herein, any notice, consent, demand, or other communication
 to be given under or in connection with this Agreement shall be in writing and shall be deemed
 duly given when delivered personally, when transmitted by facsimile transmission, one day
 after being deposited with Federal Express or other nationally recognized overnight delivery
 service, or four days after being mailed by first class mail, charges or postage prepaid,
 properly addressed, if to the Company, at its principal office, and, if to Executive, at
 Executive's address set forth following Executive's signature below. Either party
 may change such address from time to time by notice to the other.

**9.** **Governing Law; Forum; Attorneys' Fees and Costs.** This Agreement shall be governed by and
 construed and interpreted in accordance with the laws of Utah, without giving effect to any
 choice of law rules or other conflicting provision or rule that would cause the laws of any
 jurisdiction to be applied. The parties each submit to the exclusive jurisdiction of the
 federal courts (or state courts if federal jurisdiction is lacking) located within Salt Lake
 County. In the event of a lawsuit or other legal proceeding arising out of or related to
 this Agreement in which Executive prevails (as determined by the deciding court), the Company
 shall reimburse Executive for Executive's reasonable attorneys' fees and costs
 incurred in connection with such lawsuit or legal proceeding, in addition to any other relief
 to which Executive may be entitled.

**10.** **Amendments; Waivers.** This Agreement may not be modified or amended or terminated except by an instrument
 in writing, signed by Executive and a duly-authorized officer of the Company (other than
 Executive). By an instrument in writing similarly executed (and not by any other means),
 either party may waive compliance by the other party with any provision of this Agreement
 that such other party was or is obligated to comply with or perform; provided, however, that
 such waiver shall not operate as a waiver of, or estoppel with respect to, any other or subsequent
 failure. No failure to exercise and no delay in exercising any right, remedy, or power hereunder
 shall operate as a waiver thereof, nor shall any single or partial exercise of any right,
 remedy, or power hereunder preclude any other or further exercise thereof or the exercise
 of any other right, remedy, or power provided herein or by law or in equity. To be effective,
 any written waiver must specifically refer to the condition(s) or provision(s) of this Agreement
 being waived.

**11.** **Inconsistencies.** In the event of any inconsistency between any provision of this Agreement and any provision
 of any Company arrangement, the provisions of this Agreement shall control, unless Executive
 and the Company otherwise agree in a writing that expressly refers to the provision of this
 Agreement that is being waived.

**12.** **Assignment.** Except as otherwise specifically provided herein, neither party shall assign or transfer
 this Agreement nor any rights hereunder without the consent of the other party, and any attempted
 or purported assignment without such consent shall be void; provided, however, that any assignment
 or transfer pursuant to a merger or consolidation, or the sale or liquidation of all or substantially
 all of the business and assets of the Company shall be valid, so long as the assignee or
 transferee (a) is the successor to all or substantially all of the business and assets of
 the Company, and (b) assumes the liabilities, obligations and duties of the Company, as contained
 in this Agreement, either contractually or as a matter of law. Executive's consent
 shall be required for any such transaction. This Agreement shall otherwise bind and inure
 to the benefit of the parties hereto and their respective successors, permitted assigns,
 assigns, heirs, legatees, devisees, executors, administrators, and legal representatives.

**13.** **Voluntary Execution; Representations.** Executive acknowledges that (a) Executive has consulted with
 or has had the opportunity to consult with independent counsel of their own choosing concerning
 this Agreement and has been advised to do so by the Company, and (b) Executive has read and
 understands this Agreement, is competent and of sound mind to execute this Agreement, is
 fully aware of the legal effect of this Agreement, and has entered into it freely based on
 Executive's own judgment and without duress. Executive represents and warrants that
 Executive is able to successfully complete any background check and drug screening required
 by the Company pursuant to its employment policies and that Executive has not engaged in
 any conduct that would reasonably be expected to result in a failure of such background check
 or drug screening. The Company represents and warrants that it is fully authorized, by any
 person or body whose authorization is required, to enter into this Agreement and to perform
 its obligations hereunder.

**14.** **Headings.** The headings of the Sections and subsections contained in this Agreement are for convenience
 only and shall not be deemed to control or affect the meaning or construction of any provision
 of this Agreement.

**15.** **Construction.** The language used in this Agreement shall be deemed to be the language chosen by the parties
 to express their mutual intent, and no rule of strict construction shall be applied against
 any party.

**16.** **Beneficiaries/References.** Executive shall be entitled, to the extent permitted under applicable law, to select and
 change a beneficiary or beneficiaries to receive any compensation or benefit hereunder following
 Executive's death by giving written notice thereof. In the event of Executive's
 death or a judicial determination of Executive's incompetence, references in this Agreement
 to Executive shall be deemed, where appropriate, to refer to Executive's beneficiary,
 estate, or other legal representative.

**17.** **Survivorship.** Except as otherwise set forth in this Agreement, the respective rights and obligations of
 the parties shall survive any termination of Executive's employment.

**18.** **Severability.** It is the desire and intent of the parties hereto that the provisions of this Agreement be
 enforced to the fullest extent permissible under the laws and public policies applied in
 each jurisdiction in which enforcement is sought. Accordingly, if any particular provision
 of this Agreement shall be adjudicated by a court of competent jurisdiction or arbitrator
 to be invalid, prohibited, or unenforceable for any reason, such provision, as to such jurisdiction,
 shall be ineffective, without invalidating the remaining provisions of this Agreement or
 affecting the validity or enforceability of such provision in any other jurisdiction. Notwithstanding
 the foregoing, if such provision could be more narrowly drawn so as not to be invalid, prohibited,
 or unenforceable in such jurisdiction, it shall, as to such jurisdiction, be so narrowly
 drawn, without invalidating the remaining provisions of this Agreement or affecting the validity
 or enforceability of such provision in any other jurisdiction.

**19.** **No Mitigation/No Offset.** Executive shall be under no obligation to seek other employment
 or to otherwise mitigate the obligations of the Company under this Agreement, and there shall
 be no offset against amounts or benefits due to Executive under this Agreement or otherwise
 on account of any claim (other than any preexisting debts then due in accordance with their
 terms) the Company may have against Executive or any remuneration or other benefit earned
 or received by Executive after such termination.

**20.** **Counterparts.** This Agreement may be executed in any number of counterparts, each of which shall be deemed
 an original, but all such counterparts shall together constitute one and the same instrument.
 Signatures delivered by facsimile or PDF shall be effective for all purposes.

**21.** **Entire Agreement.** This Agreement contains the entire agreement of the parties and supersedes
 all prior or contemporaneous negotiations, correspondence, understandings, and agreements
 between the parties, regarding the subject matter of this Agreement.

SINTX TECHNOLOGIES, INC.

By:   <br> Eric Olson, President & CEO <br> Dated:  

EXECUTIVE

By:   <br> Ryan Elmore <br> Dated:  

Address for Notices: [\*\*\*]

**APPENDIX A**

**EXECUTIVE EMPLOYMENT AGREEMENT**

**EXECUTIVE'S DUTIES AND RESPONSIBILITIES**

Executive will have responsibility for R&D, Sales, Marketing and Regulatory Affairs with duties including but not limited to the following:

[\*\*\*]